Annals of Neurology · 2011 · 26 citations · 17 references
Life SciencesGeneticsMolecular GeneticsGlycobiologyMolecular NeuroscienceNeurogeneticsCharcot-marie-tooth DiseaseDemyelinating DiseasesDemyelinating DisordersGlycosylation PathwaysHereditary NeuropathiesProtein GlycosylationGlycosylation DefectsMissense MutationsMpz MutationsMutationMyelin Protein GlycosylationMyelin Protein Zero MutationsPeripheral Demyelinating NeuropathyPeripheral Nervous System Myelin
We report the first case of a missense mutation in MPZ causing a gain of glycosylation in myelin protein zero, the main protein of peripheral nervous system myelin. The patient was affected by a severe demyelinating neuropathy caused by a missense mutation, D32N, that created a new glycosylation sequence. We confirmed that the mutant protein is hyperglycosylated, is partially retained into the Golgi apparatus in vitro, and disrupts intercellular adhesion. By sequential experiments, we demonstrated that hyperglycosylation is the main mechanism of this mutation. Gain of glycosylation is a new mechanism in Charcot-Marie-Tooth type 1B.
17
Gains of glycosylation comprise an unexpectedly large group of pathogenic mutations
Guillaume Vogt, Ariane Chapgier, Kun Yang et al. · Nature Genetics · 2005 · 210 citations
Laurent Cotter, Murat Özçelik, Claire Jacob et al. · Science · 2010 · 186 citations
Medicine, Neurobiology, Neuroscience +17